Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.
News
Filtering
June 24, 2019 • Expert Opinion, News
Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?
June 24, 2019 • Expert Opinion, News
Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?
JAMA Internal Medicine commentary highlights opportunity to discover modifiable risk factors for dementia In a commentary published in JAMA Internal Medicine, three Regenstrief Institute  research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and cognitive impairment from observational studies, randomized clinical trials represent the only […]
Continue Reading >
May 29, 2019 • Expert Opinion
May 29, 2019 • Expert Opinion
IHS Modernization: Focus on the Patients, and the Data will Follow
By Gregory Schmidt, MD & Theresa Cullen, MD, MS Healthcare in America is a pairing of extremes. When ranked, the United States has some of the very best and the very worst healthcare metrics. Cancer survival remains the highest of any country, yet maternal deaths and infant deaths rank the worst of all developed nations. […]
Continue Reading >